Skip to main content

Table 3 Infections Due to Bacteria with Potential Coverage by Vaccines or Antibiotic Prophylaxis

From: Prevention of infection in asplenic adult patients by general practitioners in France between 2013 and 2016

➔

Preventive ongoing measures

➔

In asplenic patients vaccinated with pneumococcal vaccines

In asplenic patients vaccinated with HIB vaccine

In asplenic patients vaccinated with annual influenza vaccine

In asplenic patients vaccinated with Neisseria meningitidis vaccines

(all serogroups)

In asplenic patients receiving antibiotic prophylaxis ≥2 years

with PCV13 only

with PPSV23 only

with PCV13+PPSV23

Number of infections (lung

and/or ENT

and/or influenza)

(N = 31)

2

9

16

22

21

14

18

  1. ENT ear-nose-throat, PCV13 pneumococcal conjugate vaccine-13, PPSV23 pneumococcal polysaccharide vaccine-23, HIB Haemophilus influenza type B
Back to article page

BMC Primary Care

ISSN: 2731-4553

Contact us